These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 7004582)
1. [Sleep-waking cycle and the nyctohemeral secretion of prolactin and somatotropin in Parkinson patients. Effect of bromocriptine]. Passouant P; Besset A Bull Acad Natl Med; 1980 Feb; 164(2):134-8. PubMed ID: 7004582 [No Abstract] [Full Text] [Related]
2. [Nycterohemeral variations of growth hormone and prolactin in 6 Parkinson's sufferers treated with bromocriptine (author's transl)]. Passouant P; Besset A; Descomps B; Bonardet A; Billiard M; Nègre C Nouv Presse Med; 1979 Oct; 8(40):3237-42. PubMed ID: 534183 [TBL] [Abstract][Full Text] [Related]
3. Circadian rhythmicity of prolactin secretion in elderly subjects: changes during bromocriptine treatment. Polleri A; Masturzo P; Murialdo G; Agnoli A J Endocrinol Invest; 1981; 4(3):317-21. PubMed ID: 7320436 [TBL] [Abstract][Full Text] [Related]
4. [Pre- and postoperative differences in the circadian secretion of prolactin in carcinoma of the human breast]. Larrad Jiménez A; Caballero Asensi A; López Lazareno N Rev Esp Oncol; 1983; 30(2):139-69. PubMed ID: 6680777 [TBL] [Abstract][Full Text] [Related]
6. [Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)]. Felt V; Nedvídková J; Krejcík L; Hainer V Cas Lek Cesk; 1977 May; 116(19):591-4. PubMed ID: 406999 [No Abstract] [Full Text] [Related]
7. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas. Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021 [TBL] [Abstract][Full Text] [Related]
8. Effect of ergot alkaloids on growth hormone and prolactin secretion in humans. Silvestrini F; Liuzzi A; Chiodini PG Pharmacology; 1978; 16 Suppl 1():78-87. PubMed ID: 643905 [TBL] [Abstract][Full Text] [Related]
9. Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease. Bell RD; Carruth A; Rosenberg RN; Boyar RM J Clin Endocrinol Metab; 1978 Oct; 47(4):807-11. PubMed ID: 45469 [TBL] [Abstract][Full Text] [Related]
13. Effects of bromocriptine on the hypothalamo-pituitary axis. Flückiger E Acta Endocrinol Suppl (Copenh); 1978; 216():111-7. PubMed ID: 206087 [TBL] [Abstract][Full Text] [Related]
14. Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture. Tallo D; Malarkey WB J Clin Endocrinol Metab; 1981 Dec; 53(6):1278-84. PubMed ID: 7298804 [No Abstract] [Full Text] [Related]
15. Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Copinschi G; Van Onderbergen A; L'Hermite-Balériaux M; Szyper M; Caufriez A; Bosson D; L'Hermite M; Robyn C; Turek FW; Van Cauter E Sleep; 1990 Jun; 13(3):232-44. PubMed ID: 2356395 [TBL] [Abstract][Full Text] [Related]
16. Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy. Malarkey WB; Cyrus J; Paulson GW J Clin Endocrinol Metab; 1974 Aug; 39(2):229-35. PubMed ID: 4371345 [No Abstract] [Full Text] [Related]
17. Effects of prolactin on sleep in cyclic rats. Zhang SQ; Kimura M; Inoué S Psychiatry Clin Neurosci; 1999 Apr; 53(2):101-3. PubMed ID: 10459662 [TBL] [Abstract][Full Text] [Related]
18. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients. van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464 [TBL] [Abstract][Full Text] [Related]
19. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas. Jones TH; Figueroa CD; Smith CM; Bhoola KD Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825 [TBL] [Abstract][Full Text] [Related]
20. In-vitro effects of bromocriptine on isolated pituitary adenoma cells. Ultrastructural and morphometrical studies. Saeger W; Thiel M; Caselitz J; Lüdecke DK Pathol Res Pract; 1985 Dec; 180(6):697-704. PubMed ID: 3832005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]